share_log

Benchmark Initiates Coverage On Heart Test Laboratories with Speculative Buy Rating, Announces Price Target of $8

Benzinga Real-time News ·  Aug 8, 2022 09:44

Benchmark analyst Bruce Jackson initiates coverage on Heart Test Laboratories (NASDAQ:HSCS) with a Speculative Buy rating and announces Price Target of $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment